IOVA - CIK 0001425205
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported revenue of $263.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $263.50M | +60.6% |
| FY 2024 | $164.07M | +13699.0% |
| FY 2023 | $1.19M | - |
| FY 2018 | $0.00 | - |
| FY 2017 | $0.00 | - |
| FY 2016 | $0.00 | - |
| FY 2015 | $0.00 | - |
| FY 2014 | $0.00 | - |
| FY 2013 | $0.00 |
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported revenue of $263.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2025, IOVANCE BIOTHERAPEUTICS, INC.'s revenue grew from $0.00 to $263.50M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |